Switching TNF antagonists in patients with chronic arthritis

Switching TNF antagonists in patients with chronic arthritis - PubMed

The objective of this work is to analyze the survival of infliximab, etanercept and adalimumab in patients who have switched among tumor ...

Switching TNF-alpha antagonists in rheumatoid arthritis

We report data of patients switching from a first to a second anti-TNF-alpha from an Italian registry of patients with rheumatoid arthritis, showing that ...

[PDF] Switching TNF antagonists in patients with chronic arthritis: an ...

Analysis of patient switching of TNF antagonists in patients who have switched among tumor necrosis factor (TNF) antagonists for the treatment of chronic ...

Switch or swap strategy in rheumatoid arthritis patients failing TNF ...

TNF-α inhibitors (i.e. adalimumab, certolizumab pegol, etanercept, golimumab, infliximab and biosimilars), abatacept, tocilizumab and, under ...

Table 2 One year drug survival of first and second tumor necrosis ...

switched among tumor necrosis factor (TNF) antagonists for the treatment of chronic arthritis ... From: Switching TNF antagonists in patients with chronic ...

Switching to upadacitinib superior to cycling TNF inhibitors ... - Healio

Switching from a TNF inhibitor to upadacitinib leads to significantly better outcomes in rheumatoid arthritis vs. cycling TNF inhibitors or ...

(PDF) BIOBADASER Group. Switching TNF antagonists in patients ...

... patients who have switched among tumor necrosis factor (TNF) antagonists for the treatment of chronic arthritis. BIOBADASER is a national registry of ...

Long-term persistence of TNF-inhibitor treatment in patients with ...

Background Long-term effectiveness of tumour necrosis factor alpha inhibitors (TNFi) has mainly been explored in patients with rheumatoid arthritis (RA) and the ...

Treatment Sequences After Discontinuing a Tumor Necrosis Factor ...

Among 10,442 RA patients identified, 36.5% swapped to a non-TNFi drug, most commonly abatacept (54.2%). The remaining 63.5% cycled to a second ...

TNF Inhibitors for Rheumatoid Arthritis: Switching Therapy - HCPLive

If the patient never really got a good effect from the TNF inhibitor, your chance of getting a better outcome with another TNF is about 40%.

Switching TNF antagonists in patients with chronic arthritis: an ...

The objective of this work is to analyze the survival of infliximab, etanercept and adalimumab in patients who have switched among tumor necrosis factor ...

Observational study of switching anti-TNF agents in ankylosing ...

Finally, 46 patients, 5 with SPA, 3 with PsA and 38 with RA received a third anti-TNF agent. We conclude that anti-TNF switching in AS and PsA is less frequent ...

Optimizing outcomes in patients with rheumatoid arthritis and an ...

Despite the few controlled trials suggesting the efficacy of switching TNF inhibitors, many of the data available to support switching are ...

Rituximab versus an alternative TNF inhibitor in patients with ...

. Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid ...

A Review of Current Evidence for TNF Inhibitor Switching in ...

TNF inhibitors have been proven to be effective in treating psoriatic arthritis, however not every patient responds to or tolerates treatment.

Switching Between Biological Treatments in Psoriatic Arthritis

Survival of anti-TNFα treatment appears to be superior in PsA patients when compared with rheumatoid arthritis patients. Switching from anti-TNF ...

Switch or Swap: Strategies for Anti-TNF Failure in Rheumatoid Arthritis

However, an estimated 30% to 40% of patients treated with TNF inhibitors do not respond adequately, do not sustain response over time, or ...

Switching TNF antagonists in patients with chronic arthritis: An ...

Switching TNF antagonists in patients with chronic arthritis: An observational study of 488 patients over a four-year period. Gomez-Reino, J.J. · Carmona, L ...

Switching TNFα antagonists in patients with ankylosing spondylitis ...

... A longitudinal observational prospective study 105 Switching to a second anti-TNF agent was necessary in 24% of the AS patients, and 11% of ...

When Should You Change Your TNF Blocker? - Verywell Health

Rheumatoid arthritis or spondyloarthritis patients who are treated with a TNF blocker may, at some point, need to switch to another biologic ...